14-16
Dec
2026
CPHI Middle East 2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
H2.G14

Laboratoires Medis

About Laboratoires Medis

Médis is an international pharmaceutical company based in Tunisia, dedicated to improving the health and well-being of people worldwide. With a strong commitment to innovation, we develop, manufacture, and market a wide range of high-quality pharmaceutical products. Our extensive portfolio covers various therapeutic areas, including cardiology, oncology, and infectious diseases. By fostering partnerships with healthcare professionals and adhering to stringent quality standards, Médis has established itself as a trusted leader in the pharmaceutical industry. Our products are exported to numerous countries, particularly in the Middle East region. Notably, a range of our products has been avail...

Meet us at

  • CPHI Middle East 2026

    Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
    14 Dec 2026 - 16 Dec 2026
  • Country/Region:
    Tunisia
  • On CPHI since:
    2024
Company types
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
  • Route De Nabeul KM7, Nabeul, Tunisia

Products from Laboratoires Medis (5)

  • Contrast Media

    Product Contrast Media

    injectable contrast media : IOHEXOL - IOPAMIDOL - IOPROMIDE
  • Dry Powder Inhalation

    Product Dry Powder Inhalation

    FORMOTEROL - BUDESONIDE - TIOTROPIUM
  • ENOXA

    Product ENOXA

    Enoxaparin in pre-filled syringe
  • Hematology products

    Product Hematology products

    AZACITIDINE - BORTEZOMIB - DASATINIB - FLUDARABINE - LENALIDOMIDE
  • Oncology products

    Product Oncology products

    ABIRATERONE - ANASTROZOLE - CAPECITABINE - DACARBAZINE - DOCETAXEL - GEMCITABINE - IMATINIB - LETROZOLE - PACLITAXEL - PEMETREXED - SUNITINIB - TEMOZOLOMIDE